Announce Date | 08/06/2025 |
EPS Normalized Actual | $2.68 (Beat by $0.28) |
EPS GAAP Actual | $2.68 (Beat by $0.28) |
Revenue Actual | $10.438B |
Revenue Surprise | Beat by $10438M |
Announce Date | 12/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.81174 |
EPS GAAP Estimate | $0.81174 |
Revenue Estimate | $5.466516386B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 4.23148 | 14.15 | 3.91993 | 4.58197 | 1 |
Dec 2028 | 5.05226 | 11.85 | 4.67141 | 5.46074 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 2.51 | 0.0928 | 10.438B | 2.72% | -404.98M |
FQ1 2025 (Mar 2025) | 0.02 | -0.40705 | 5.1B | -5.19% | -94.22M |
FQ4 2024 (Dec 2024) | 0.23 | -0.39172 | 4.864B | -19.67% | -519.57M |
FQ3 2024 (Sep 2024) | 0.0364 | 0.0364 | 5.348B | -5.29% | 5348M |
FQ2 2024 (Jun 2024) | 0.78 | 0.78 | 10.1539B | -14.77% | 10153.9M |
FQ1 2024 (Mar 2024) | 0.32 | 0.32 | 5.36493B | -13.83% | 5364.93M |
FQ4 2023 (Dec 2023) | 0.36 | 0.36 | 5.82054B | -29.42% | 5820.54M |
FQ3 2023 (Sep 2023) | 0.15 | 0.15 | 5.631B | 100% | 5631M |
FQ4 Announce Date
12/30/2025 (Pre-Market)
Consensus EPS Estimates
0.81174
Consensus Revenue Estimates
5.466516386B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.32888 | -- | 0.30904 | 0.34332 | 7 |
FQ3 2027 (Sep 2027) | 0.18793 | -- | 0.17659 | 0.19618 | 4 |
FQ2 2027 (Jun 2027) | 2.0368 | -- | 1.91393 | 2.12625 | 3 |
FQ1 2027 (Mar 2027) | 0.5661 | -- | 0.53195 | 0.59096 | 7 |
FQ4 2026 (Dec 2026) | 0.4881 | -- | 0.44414 | 0.5361 | 9 |
FQ3 2026 (Sep 2026) | 0.1493 | -- | 0.13771 | 0.16163 | 3 |
FQ2 2026 (Jun 2026) | 2.05554 | -22.11 | 1.89599 | 2.2253 | 3 |
FQ1 2026 (Mar 2026) | 0.49247 | 95.94 | 0.44811 | 0.5409 | 4 |
FQ4 2025 (Dec 2025) | 0.81174 | 71.67 | 0.73862 | 0.89157 | 9 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 4.96B | -- | 4.73B | 5.12B | 2 |
FQ3 2027 (Sep 2027) | 4.89B | -- | 4.66B | 5.05B | 2 |
FQ2 2027 (Jun 2027) | 9.87B | -- | 9.41B | 10.21B | 2 |
FQ1 2027 (Mar 2027) | 5.11B | -- | 4.87B | 5.28B | 2 |
FQ4 2026 (Dec 2026) | 5.46B | -- | 5.08B | 5.87B | 3 |
FQ3 2026 (Sep 2026) | 5.24B | -- | 4.93B | 5.58B | 4 |
FQ2 2026 (Jun 2026) | 11.19B | 6.69 | 10.52B | 11.9B | 5 |
FQ1 2026 (Mar 2026) | 5.51B | 7.39 | 5.13B | 5.92B | 3 |
FQ4 2025 (Dec 2025) | 5.47B | 11.02 | 5.09B | 5.88B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 2.4172 | 2.51 | 0.0928 | 3.7% |
FQ1 2025 (Mar 2025) | 0.42705 | 0.02 | -0.40705 | -2035.25% |
FQ4 2024 (Dec 2024) | 0.62172 | 0.23 | -0.39172 | -170.31% |
FQ3 2024 (Sep 2024) | 0.0364 | 0.0364 | 100% | |
FQ2 2024 (Jun 2024) | 0.78 | 0.78 | 100% | |
FQ1 2024 (Mar 2024) | 0.32 | 0.32 | 100% | |
FQ4 2023 (Dec 2023) | 0.36 | 0.36 | 100% | |
FQ3 2023 (Sep 2023) | 0.15 | 0.15 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $10.84B | $10.44B | $-404.98M | -3.88% |
FQ1 2025 (Mar 2025) | $5.19B | $5.1B | $-94.22M | -1.85% |
FQ4 2024 (Dec 2024) | $5.38B | $4.86B | $-519.57M | -10.68% |
FQ3 2024 (Sep 2024) | $0B | $5.35B | $5348M | 100% |
FQ2 2024 (Jun 2024) | $0B | $10.15B | $10153.9M | 100% |
FQ1 2024 (Mar 2024) | $0B | $5.36B | $5364.93M | 100% |
FQ4 2023 (Dec 2023) | $0B | $5.82B | $5820.54M | 100% |
FQ3 2023 (Sep 2023) | $0B | $5.63B | $5631M | 100% |